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Background: Dental caries is an infectious disease which results from the acidic demineralisation of the tooth
enamel and dentine as a consequence of the dental plaque (a microbial biofilm) accumulation. Research showed
that several foods contain some components with antibacterial and antiplaque activity. Previous studies indicated
antimicrobial and antiplaque activities in a low-molecular-mass (LMM) fraction of extracts from either an edible
mushroom (Lentinus edodes) or from Italian red chicory (Cichorium intybus).
Methods: We have evaluated the antimicrobial mode of action of these fractions on Streptococcus mutans, the
etiological agent of human dental caries. The effects on shape, macromolecular syntheses and cell proteome
were analysed.
Results: The best antimicrobial activity has been displayed by the LMM mushroom extract with a bacteriostatic
effect. At the MIC of both extracts DNA synthesis was the main macromolecular synthesis inhibited, RNA synthesis
was less inhibited than that of DNA and protein synthesis was inhibited only by roughly 50%. The partial inhibition
of protein synthesis is compatible with the observed significant increase in cell mass. The increase in these
parameters is linked to the morphological alteration with transition from cocci of the untreated control to elongated
cells. Interestingly, these modifications were also observed at sub-MIC concentrations. Finally, membrane and cytosol
proteome analysis was conducted under LMM mushroom extract treatment in comparison with untreated S. mutans
cells. Significant changes were observed for 31 membrane proteins and 20 of the cytosol fractions. The possible role
of the changed proteins is discussed.
Conclusions: This report has shown an antibiotic-like mode of action of mushroom and chicory extracts as
demonstrated by induced morphogenetic effects and inhibition of specific macromolecular synthesis. This feature as
well as the safe use of this extract as result of its natural origin render the LMM both mushroom and chicory extracts
suitable for the formulation into products for daily oral hygiene such as mouthwashes or toothpastes.
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Dental caries is an infectious disease of worldwide im-
portance [1,2]. It results from the acidic demineralisa-
tion of the tooth enamel and dentine as a consequence
of the dental plaque (a microbial biofilm) accumulation
[3,4]. Streptococcus mutans and Streptococcus sobrinus
are considered the main etiological agents of human den-
tal caries due to their efficient colonization of the dental
surface, efficient carbohydrate metabolism and lactic acid
production (acidogenicity) and aciduricity (i.e. the cap-
ability to survive and multiply in acidic environment)
[1,2]. Although cariogenic streptococci are included
among the normal oral microbiota of humans, both
diet and inefficient oral hygiene are the trigger for dis-
ease initiation and progression [3]. Tooth colonization
by S. mutans is conventionally subdivided in a sucrose-
independent and a sucrose-dependent phase. Initially,
several adhesins of the odontopathogenic bacteria interact
with the salivary glycoproteins of the acquired pellicle on
teeth surface via bivalent cations (mainly Ca++). During the
second phase bacteria adhere tightly to tooth surface as a
result of the production of exopolysaccharides (glucans)
from sucrose by the activity of distinct glucosyl trans-
ferases (GTFs) which act sequentially to produce a
final, very hydrophobic, glucan called “mutan”. This is
responsible for the final tight adhesion of bacteria to
tooth surface. If dental plaque is allowed to accumulate,
mutans streptococci efficiently metabolize sucrose (or
sugar polymers such as starch) to produce large amount of
lactic acid capable of solubilising the mineral component
of the tooth and to initiate the carious process [1,2]. Sev-
eral preventive strategies can be used to inhibit or slow
down the cariogenic process. These range from fluoride
administration, typically in toothpastes to strengthen the
enamel and dentine (by substituting Cl- for F-) to better
resist the acid damage, to reduction in sugar diet or use
of sugar substitutes (e.g. sorbitol and aspartame) [1,2].
However, it is generally accepted that lowering the oral
bacterial count (i.e. dental plaque removal) is an effective
method for preventing caries development. The manual
dexterity of many individuals, however, is not very efficient
and good oral hygiene is difficult to maintain. In order to
compliment the mechanical nature of the cleaning mouth-
washes and toothpastes which contain compounds with
antimicrobial and antiplaque activities are recommended.
Research performed over the last three decades has
shown that, contrary to the popular belief that foods
have a negative impact on oral health, several foods con-
tain some components with antibacterial and antiplaque
activity for recent reviews see ref. [5,6]. It seems reason-
able, thus, to encourage the consumption of such foods
and/or incorporate the active compound(s) in functional
foods or in cosmetic products for daily oral hygiene [7].
Furthermore, the trend for using “natural” compoundsfor oral health products instead of those obtained by
chemical synthesis is gaining momentum. Previous stud-
ies have shown antimicrobial and antiplaque activities in
a low-molecular-mass (LMM) fraction of extracts from
either an edible mushroom (Lentinus edodes, very popu-
lar in Japan and called shiitake) or from Italian red chic-
ory (early Treviso red chicory, an anthocyanic cultivar of
Cichorium intybus) [8-10].
In this work we have evaluated in some detail the anti-
microbial mode of action of the LMM fractions of
mushroom and chicory aqueous extracts on S. mutans,
the main etiological agent of human dental caries.
Methods
Bacterial strains and growth conditions
S. mutans UA159 was used throughout this study. Cells
were grown in brain hearth infusion broth (BHIB) or on
brain hearth infusion agar (BHIA) (Oxoid Ltd, Basingstoke,
England). Cultures were incubated at 37°C in an atmos-
phere enriched with 5% CO2. Growth of S. mutans in a
biofilm structure was allowed on ceramic hydroxyapatite
(HA) discs (Clarkson Chromatography Products Inc.,
South Williamsport, PA, USA). To achieve this, HA
discs (2.5 mm diameter for SEM or 25 mm for the
other experiments) were coated with sterile human sal-
iva collected from a pool of donors [11]. Each disc was
then incubated in 5 ml of BHIB medium spread with a
S. mutans culture in a well of a 6-well tissue culture
plate (35 mm diameter, flat bottom, Sarstedt, Verona,
Italy) at 37°C in the capnophylic atmosphere. Every day
(for a total of three days) culture supernatants were re-
moved by gentle aspiration and replaced with fresh
medium. In order to analyse the effects of the test
compound, on 3 day old biofilms a suitable concen-
tration of LMM fraction of mushroom extract was
added to the growth medium and incubated for additional
3 hours. At the end of each incubation, biofilms were
washed three times with sterile distilled water and then
fixed with 2.5% glutaraldehyde in 0.1 M phosphate buffer
pH 7.2 for SEM analysis.
LMM fraction of both mushroom and chicory extract
Frozen Shiitake mushroom was purchased from Asiago
Food SpA, Veggiano, Padua, Italy, and red chicory from
The Italian Consorzio Radicchio di Treviso, Treviso,
Italy. Both mushroom and red chicory juices were pre-
pared by homogenization of frozen fungi and fresh vege-
table. To do this, aliquots (400 g) of frozen fungi or
aliquots (500 g) of fresh red chicory, were homogenized
for 2 min and centrifuged for 10 min at 8,000 × g. Both
juices, after separation from the solid part, were filtered
on paper filter and then sterilized by ultrafiltration. The
LMM fractions (< 5,000 Daltons) of both shiitake mush-
room and red chicory were prepared by ultrafiltration of
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system (Vivascience AG, Hannover, Germany) equipped
with a membrane 5,000 MWCO PES for ultradiafiltration,
as described elsewhere [8]. About 70 and 50% (w/w) of the
components originally present in the crude mushroom and
chicory homogenates, respectively, were detected in the
ultradiafiltrates. The ultradiafiltrates were sterilized using a
0.20 μm pore size membrane (Vivascience), then freeze-
dried and stored up to 3 months at −80°C. Immediately be-
fore use, a sample was rehydrated with sterile distilled
water to obtain a 10x solution and kept at 4°C for
no longer than a week. The 1x concentration of the
LMM fraction after reconstitution represents the ori-
ginal concentration in the food.
Evaluation of cell growth and viability
Optical density (O.D.) was measured at 640 nm wave-
length with a Beckman mod. DU 530 spectrophotom-
eter. Total bacteria were counted as cell particles with a
Coulter Counter mod ZBI (Coulter Scientific) equipped
with a 30 μm capillary. Viable cells were determined as
colony forming units (CFU) per ml of culture. Suitable
dilutions in sterile saline solution of the untreated and
treated cultures were plated on BHIA and plates incubated
at 37°C for 24 hours in the capnophylic atmosphere.
Evaluation of DNA, RNA and protein synthesis
Aliquots of an exponentially growing culture (150 μl,
O.D. 0.2 unit) were placed in the wells of a microti-
tre plate together with 5 μCi of [3H] thymidine (spec.
act. >10 Ci/mmol) or [3H] uridine (spec. act. >20 Ci/mmol)
or [3H] leucine (spec. act. 50 Ci/mmol, PerkinElmer Life
and Analytical Science, Boston, MA, USA). In some wells
suitable dilutions of the test compounds were added.
Each determination was performed in triplicate. Microti-
ter plates were incubated at 37°C in the capnophylic at-
mosphere for 60 min. At the end of this time period the
culture was overlaid on a Millipore GF/C glass fibre
paper soaked in advance with 10% trichloroacetic acid
(TCA) and plunged in a cold 10% TCA solution. Filters
were then washed three times with cold TCA and, finally,
twice with acetone. Radioactivity was determined with a
Beckman LS 6500 liquid scintillation counter. Three dis-
tinct identical experiments were performed.
Scanning electron microscopy (SEM)
SEM was performed within a week of fixation of the
samples. Glutaraldehyde-fixed samples from both plank-
tonic and biofilm cultures were washed three times with
phosphate buffer followed by three rinses in distilled water.
Specimens were then serially dehydrated in ethanol and
subjected to freeze drying, mounted on metal stubs and
sputter-coated with gold. Each specimen was viewed with
an ESEM FEG XL30 electron microscope (Fei-Philips) atmagnifications of x5,000 to x40,000. [12]. Cell length
measurement was performed on 150 bacteria per sample
at x10,000 magnification by Image J software (http://
rsbweb.nih.gov/ij/index.html). Data handling and curve fit-
ting with a bimodal Gaussian distribution were performed
by Microcal Origin 6.0 (Northampton, MA, USA).
Cytoplasmic and membrane protein extraction for
proteome analysis
One litre of an exponentially growing culture of S. mutans
UA159 (O.D. 0.8 units) and one litre of a same culture
treated for 60 min with 2x mushroom extract were rapidly
chilled in ice and immediately centrifuged in a Sorvall RC-
5B refrigerated centrifuge with a GS-3 rotor (5,000 ×g for
10 min). Pellets were washed three times with cold 50 mM
phosphate buffer (ph 7.2) and cells fragmented with glass
beads (0.10 mm) in a B. Braun Cell Disruptor (B. Braun,
Melsungen, Germany) under a continuous CO2 flow
to keep the vial refrigerated. Unbroken cells were re-
moved by centrifugation at 2,500 ×g for 10 min at 4°C
and supernatant was centrifuged at 30,000 ×g with a
type 40 rotor in a Beckman Optima LE-80 K ultracen-
trifuge (Beckman Coulter, Inc.) for 60 min. Supernatant
(cytoplasmic fraction) was removed and pellet (cyto-
plasmic membrane and cell wall) washed with phosphate
buffer and centrifuged as above three times. Cytoplasmic
fractions of treated and untreated S. mutans were precipi-
tated with 15% of trichloroacetic acid (TCA) in ice and
resuspended in 1 ml of a solution containing 1 M Tris,
4 M NaCl, 2% cetyl-trimethylammonium bromide (CTAB)
and 1× protease inhibitor cocktail tablet (Complete, Mini;
La Roche). Proteins were purified as previously described
by Polati et al. [13]. Briefly, nine volumes of double dis-
tilled water were added to the supernatants and samples
were centrifuged 20,000xg for 10 min to remove DNA
and polysaccharides. Proteins were then precipitated by
addition of four volumes of cold acetone and purified by
centrifugation at 20 000 × g for 10 min, and by washing
the precipitates twice with absolute ethanol and twice
with acetone. As far as the membrane proteins were
concerned, the extraction from treated and untreated
cells was carried out according to Zuobi-Hasona et al.
[14]. Membrane pellet was resuspended in 500 μl (NH4)
HCO3 50 mM and 3 ml of a 2:1 (v/v) trifluoroethanol/
chloroform mixture were added to the sample which was
maintained at 0°C for 1 h vortexing every 5 min for
10 sec each. The mixture was centrifuged at 10,000xg
for 5 min and the insoluble interphase was removed, and
the remaining mixture was dried using an Eppendorf
Vacufuge vacuum centrifuge (Eppendorf srl, Milan, Italy).
The residue was suspended in a solubilisation buffer
consisting of 7 M urea, 2 M tiourea, 4% CHAPS, 0,5%
ASB14, 2% Triton X-100, pH 3–10 Ampholyte (Fluka,
Buchs SG, Switzerland). Proteins were then precipitated
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centrifugation at 20 000× g for 10 min. All the resulting
protein pellets, both from cytoplasmic and from mem-
brane fractions, were solubilised with a solution containing
7 M urea, 2 M thiourea, 3% CHAPS, 20 mM Tris. Then
1% pH 3–10 Ampholyte was added and samples were
centrifuged for 30 min to remove residual contaminants
complexed with ampholytes. Samples were incubated with
5 mM tributyl phosphine and 20 mM acrylamide for
60 min at room temperature to reduce protein disulphide
bonds and alkylate the cysteine thiolic groups. The reaction
was blocked by the addition of 10 mM DTT Q and sam-
ples were stored at −80°C. Protein concentration was eval-
uated with Bradford assay [15].
Two-dimensional gel electrophoresis (2-DE)
Protein fractionation by 2-DE was performed by rehy-
drating seven cm long, pH 3–10 immobilized pH gra-
dient strips (IPG; Bio-Rad Laboratories, Hercules, CA,
USA) for 6 h with 150 μL of the sample solution
containing 800 μg of total protein from S. mutans
cells. Isoelectric focusing (IEF) was carried out with a
Protean IEF Cell (Biorad), with a low initial voltage and
then by applying a voltage gradient up to 5,000 V with
a limiting current of 50 μA/strip and the temperature
was set at 20°C. For the second dimension, the IPGs
strips were equilibrated for 26 min by rocking in a solu-
tion of 6 M urea, 2% SDS, 20% glycerol, 375 mM Tris–
HCl, pH 8.8. The IPG strips were then laid on 10-20%
gradient SDS-PAGE with 0.5% agarose in the cathode
buffer (192 mM glycine, 0.1% SDS and Tris–HCl to
pH 8.3). The electrophoretic run was performed by set-
ting a current of 5 mA for each gel for 30 min, then
10 mA/gel for 1 h, and 20 mA/gel until the end of the
run. During the run the temperature was set at 11°C.
The protein spots were revealed with Sypro Ruby stain
(Life Technologies Corporation).
Image analysis
The image analysis of the 2D gels replicates was performed
by PDQuest software (Bio-Rad), version 7.3. Each gel was
analyzed for spot detection, background subtraction and
protein spot OD intensity quantification. The gel image
showing the higher number of spots and the best protein
pattern was chosen as a reference template, and spots in a
standard gel were then matched across all gels. Spot quan-
tity values were normalized in each gel dividing the raw
quantity of each spot by the total quantity of all the spots
included in the standard gel. Two distinct differential ana-
lyses were performed, one for cytoplasmic proteins and
one for membrane fractions. In both the experiments gels
were divided in two separated groups (control and treated
samples) and, for each protein spot, the average spot quan-
tity value and its variance coefficient in each group weredetermined. A Student's test was performed in order to
compare the two groups and identify sets of proteins that
showed a statistically significant difference with a confi-
dence level of 0.05.
Peptide sequencing by nano HPLC-ESI-MS/MS
In gel digestion by trypsin was performed, according to
Shevchenko et al. [16]. Peptide mixtures were separated
by using a nanoflow-HPLC system (Agilent Technologies
series 1200, Santa Clara, CA, USA). A sample volume of
10 μl was loaded by the autosampler onto a 0.3 mm fused
silica pre-column (75 μm I.D.; 375 μm O.D.) at a flow
rate of 10 μl/min. Sequential elution of peptides was
accomplished by using a flow rate of 250 nl/min and a
linear gradient from Solution A (2% acetonitrile; 0.1%
formic acid) to 50% of Solution B (98% acetonitrile; 0.1%
formic acid) in 40 minutes over the pre-column in-line
with a homemade 15 cm resolving column (75 μm I.D.;
375 μm O.D.; Zorbax 300-SB C18, Agilent Technologies).
Peptides were eluted directly into an ion Trap (model Es-
quire 6000, Bruker-Daltonics, Bremen, Germany). Capillary
voltage was 1.5-2 kV and a dry gas flow rate of 10 L/min
was used with a temperature of 230°C. The scan range
used was from 300 to 1800 m/z. Protein identification was
performed by searching in the National Center for Biotech-
nology Information non-redundant database (NCBInr)
using the Mascot program (http://www.matrixscience.
com). The following parameters were adopted for database
searches: complete carbamidomethylation of cysteines
and partial oxidation of methionines, peptide Mass Tol-
erance ± 1.2 Da, Fragment Mass Tolerance ± 0.9 Da,
missed cleavages 2. For positive identification, the score
of the result of [−10 × Log(P)] had to be over the signifi-
cance threshold level (p < 0.05).
Chemicals and reagents
Unless otherwise specified, chemicals and reagents were
purchased from Sigma Aldrich, St. Louis, MO, USA).
Results
Effects of LMM fractions of both mushroom and chicory
extracts on cell growth and viability of S. mutans
Different concentrations of LMM fraction of either mush-
room or chicory were tested on cell growth of S. mutans.
Figure 1 shows the effects of different concentrations
on increase in optical density, cell particle number,
and cell viability of S. mutans. As far as the LMM
fraction of mushroom extract concerned (Figure 1,
column A), the concentration of 2x was the minimum
capable of inhibiting cell division of S. mutans as
evaluated by cell particle counts, while 1x allowed a
slight increase of the total cell number over the ex-
periment and corresponded to two doublings. On the
contrary, both concentrations only partially reduced
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Figure 1 Effects on cell mass, cell number, and cell viability of S. mutans treated with different concentration of LMM fraction of
mushroom (column A) and chicory (column B). Column A symbols: ( ◊ ) untreated control, ( ■ ) 1x, ( ▲ ) 2x; column B symbols: ( ◊ )
untreated control, 2x ( ● ), 6x ( ♦ ) concentration.
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http://www.biomedcentral.com/1472-6882/13/117O.D. increase in a dose-dependent manner. Evaluation
of cell viability indicated a bacteriostatic effect of the
2x concentration. Concentrations of LMM fraction of
chicory extract were also tested in S. mutans (Figure 1,column B). As compared with LMM fraction of mushroom
extract, the 2x concentration was endowed of very limited
inhibitory activity. Only 6x concentration was capable of
complete inhibition of cell division but without exerting
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in O.D. of the culture was observed.
Effects of LMM fraction of mushroom and chicory extracts
on macromolecular synthesis of S. mutans
DNA, RNA and protein synthesis of S. mutans were evalu-
ated in the presence of the above reported active concen-
trations (i.e. the minimal inhibitory and a sub-inhibitory
concentration). Table 1 summarises the results: strong in-
hibitory effect on DNA synthesis was observed during
treatment with 2x or 6x concentration of mushroom and
chicory extracts, respectively, with a residual synthesis
lower than 10% of the untreated control. The 1x or 2x sub-
inhibitory concentration of mushroom and chicory ex-
tracts, respectively, allowed roughly 24-36% DNA synthe-
sis. RNA synthesis, albeit to a lesser extent compared with
DNA synthesis, was reduced to roughly 20% of the control
in the presence of the inhibitory concentrations and to 34-
54% of the control in the presence of the sub-inhibitory
concentration of both mushroom and chicory extracts, re-
spectively. Protein synthesis was inhibited by roughly 50%
in the presence of the inhibitory dose of both mushroom
and chicory extracts and to a lesser extent (11-39%) by
sub-inhibitory concentrations.
Morphological examination and cell size distribution of
S. mutans treated with LMM fractions of mushroom and
chicory extracts
Bacteria treated as above were also collected for morpho-
logical analysis by either optical and scanning electron mi-
croscopy. Preliminary observation by optical microscopy
showed the presence of elongated cells as a result of the
treatment. Thus, we resorted to SEM analysis in order to
precisely evaluate cell size and distribution. Figure 2 shows
the appearance of S. mutans during treatment with 2x
LMM fraction of the mushroom extract. Elongated cells
with interrupted septa were seen after a three-hour treat-
ment, while untreated control cells presented the typicalTable 1 Macromolecular synthesis of S. mutans treated for
60 min. with different concentrations of LMM fractions of
both mushroom and chicory extracts
LMM fraction Concentration Macromolecular synthesis
DNA RNA Protein
mushroom 0 100 b 100 b 100 b
1x a 24 34 61
2x 8 21 49
chicory 0 100 c 100 c 100 c
2x a 36 54 89
6x 6 19 44
a Subinhibitory dose.
b Control values were: DNA, 287,085 cpm; RNA, 137,216; protein, 9,208.
c Control values were: DNA, 252,718 cpm; RNA, 132,519; protein, 8,749.streptococcal appearance as ovoidal cells. Similar morpho-
logical changes were observed during treatment with the
6x chicory extract as well as with the above reported sub-
inhibitory concentration of both mushroom and chicory
(data not shown). Table 2 shows the mean cell length with
additional parameters of the treated cells in comparison
with the untreated ones. Measures confirmed the morpho-
logical changes at the inhibitory concentration, however it
is worth of note that elongation has been observed also in
cells treated with sub-inhibitory concentrations. Further-
more, analysis of the size distribution of untreated control
S. mutans cells showed that the characteristic Gaussian bi-
modal distribution, i.e. just divided single cells and doubled
cells prior of dividing, as previously reported for strepto-
cocci, was no longer evident in treated cells as a result of
global cell elongation (Figure 3).
In a further set of experiments we evaluated the effects
of the LMM fraction of mushroom extract on S. mutans
biofilm architecture. Figure 4 shows that untreated
control biofilm appeared as a compact structure with
bacteria close to one another, while in treated biofilm
several gaps were observed.
Proteome analysis of S. mutans treated with LMM fraction
of mushroom
Proteome analysis was conducted in both cytoplasmic
and membrane fractions of S. mutans. Figure 5 shows
a representative separation by 2D-PAGE of the cytosol
or membrane proteins of an untreated and a treated
S. mutans culture. Several dozen of protein spots that
significantly either increased or lowered in treated cells
in comparison with those corresponding of the un-
treated control, were identified after peptide sequen-
cing by nano HPLC-ESI-MS/MS. Only proteins that
quantitatively changed ±2 fold were considered signifi-
cantly varied. Table 3 summarises results by grouping
the vast majority of the 31 changed membrane proteins
on the base of their physiological roles. Interestingly,
all (eight) proteins involved in membrane transport
significantly decreased, while several other proteins
involved in sugar biosynthesis and metabolism, pro-
tein biosynthesis and folding, cell cycle and division,
aminoacid biosynthesis and metabolism, or miscellanea
were either up-regulated or down-regulated in treated
S. mutans cells. Table 4 summarises results of the study
of the cytosol fraction of either control or treated cells.
A total of 20 proteins were analysed for their sequence
but only one of them remained unidentified. Grouping
on the base of their physiological roles have been
achieved: 5/5 proteins involved in stress response (e.g.
GroEL, GroES, DnaK, SodA, GshR) and 4/4 involved in
cell redox homeostasis were all significantly up-regulated,
while of the 6 proteins involved in sugar biosynthesis and
metabolism 4 were down- and 2 up-regulated, and, finally,
A B
Figure 2 Scanning electron microscopy of untreated S. mutans (column A) and after a three-hour treatment with 2x of LMM fraction of
mushroom extract (column B) at different magnifications.
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proteins involved in protein biosynthesis and folding.
Discussion
Although foods have to be considered deleterious for
oral health in that capable of sustaining growth of oralTable 2 Cell length measurement of S. mutans cells
treated for three hours with different concentrations of
LMM fractions of both mushroom or chicory extracts in
comparison with control cells at the same time
Microorganism Growth
condition
Cell length (μm)
Mean SD Min.
value
Max.
value
Mode
S. mutans control 0.78 0.16 0.48 1.28 0.59
Mushroom 1x a 0.89 0.18 0.56 1.47 0.78
Mushroom 2x 0.98 0.23 0.60 1.82 0.84
Chicory 2x a 0.86 0.18 0.55 1.46 0.75
Chicory 6x 0.95 0.23 0.60 1.60 0.82
a Subinhibitory dose.bacteria (e.g. sucrose-rich foods and dental caries), how-
ever a large number of scientific reports indicates that
several commonly consumed foods and beverages of nat-
ural origin contain substances with a beneficial impact
on oral health [5-7,17]. The healthy effects are attributed
mainly to the polyphenol fraction which is present in a
large number of vegetables [7]. These compounds have
been shown to have antimicrobial, antiadhesive, antiplaque
activities, thus the consumption of these foods and bever-
ages could be encouraged in order to improve oral hygiene.
Epidemiological studies have shown that people consum-
ing foods rich in bioactive compounds have an improved
oral health (e.g. tea drinkers have a less risk of dental
caries) [5]. Furthermore, attempts to formulate active
natural compounds as anticaries and/or antigingivitis
oral rinses for daily oral hygiene have shown encour-
aging results, although a limited number of pilot clin-
ical trials have been performed [5,6,18-22]. Among
the numerous foods and drinks tested, the LMM frac-
tion of both shiitake mushroom and red chicory aque-
ous extract has been previously demonstrated to be
Length (µm)
Length (µm)
Ce
lls
 (%
)
Ce
lls
 (%
)
Length (µm)
Ce
lls
 (%
)
B
C
A Figure 3 Cell length distribution of S. mutans (A) and after a
three-hour treatment with 1x (B) and 2x (C) LMM fraction of
mushroom extract. X1 (centre of the first Gaussian fit) values were
0.663 for image A, 0.761 for B and 0.806 μm for C; W1 (width at
half maximum of the first Gaussian fit) values were 0.101, 0.218 and
0.126 μm for images A, B and C, respectively; X2 (centre of the
second Gaussian fit) values were 0.955, 1.047 and 0.993 μm for
images A, B and C, respectively; W2 (width at half maximum of the
second Gaussian fit) values were 0.342, 0.342 and 0.45 μm for
images A, B and C, respectively.
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them of special interest as components of products for
daily oral hygiene [8-10,21,22]. In this report we have
evaluated the possible mode of action of these extracts
on growth, morphology and physiology of S. mutans,
the etiological agent of human dental caries. Of the two
extracts tested, the best antimicrobial activity has been
displayed by the LMM mushroom extract with a minimalA
B
Figure 4 Scanning electron microscopy of S. mutans grown in
biofilm state (A) and after treatment with 2x LMM fraction of
mushroom extract (B). Magnification x12,000.
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Figure 5 2DE cytosol (A) and membrane (C) protein profile of S. mutans and after treatment with 2x LMM fraction of mushroom
extract (B and D, respectively).
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ural concentration of the vegetable, while the LMM
fraction of chicory extract inhibited growth only at 6x
concentration. Inhibition of cell division resulted in
bacteriostatic effect in both cases. At the minimal in-
hibitory concentration of both extracts DNA synthesis
was the main macromolecular synthesis inhibited,
resulting in a residual synthesis less than 10%, RNA
synthesis, although strongly inhibited, was less than
that of DNA and, finally protein synthesis was inhibited
only by roughly 50%. The residual RNA synthesis and
the partial inhibition of protein synthesis is compatible
with the observed significant increase in O.D as result
of cell mass increase. The increase in these parame-
ters is, in turn, linked to the morphological alteration
observed by electron microscopy with transition from
cocci or slightly elongated cocci of the untreated con-
trol to elongated rods as the consequence of septum
synthesis inhibition as effect of the treatment. Ana-
lysis of cell size distribution confirms this statement:
the typical bimodal distribution of the streptococcal
growing control was shifted to higher values when cellselongated. These results are in agreement with the previ-
ous observations of the typical mode of cell wall growth
and division of streptococci and enterococci [23,24].
The fact that tested natural extracts act by blocking
cell division after primary inhibition of DNA synthe-
sis is reminiscent of the chemotherapeutic agents in-
cluded in the quinolone family [25]. Furthermore, the
peculiar response of the macromolecular synthesis
and the characteristic morphogenetic effects as a result
of the treatment with either mushroom or chicory ex-
tracts have also been observed, similarly to quinolones,
at sub-inhibitory doses [25]. The morphogenetic ef-
fects induced by mushroom or chicory treatment on
S. mutans cells are indeed similar to those observed
in streptococcal thermo-sensitive division mutants when
incubated at non-permissive temperature or exposed to
both sub- and inhibitory doses of β-lactam antibiotics [26].
These considerations as a whole lend further support to
the hypothesis that the mode of action is comparable to
that of antimicrobial families such as quinolones and
β-lactams, thus, an antibiotic-like mode of action is
suggested for these compounds [25,27,28].
Table 3 Identification by nano HPLC-ESI-MS/MS of S. mutansmembrane proteins differentially expressed when treated with 2x LMM fraction of mushroom extract
Protein name Spot
no.
Fold of
variation
NCBI acc. # Gene name Theor. Mr.
(Da)
Theor. pI No. of peptides
identified
Mascot
score a)
Sequence
coverage b) (%)
Molecular function
MEMBRANE TRANSPORT
F0F1 ATP synthase subunit delta 2202 - 2.27 gi|24379920 atpH 20436 5.22 9 528 51 ATPase activity
Putative ABC transporter, ATP-binding protein 5303 - 2.08 gi|24380277 psaA 26297 5.58 12 694 57 ATPase activity
Putative oligopeptide ABC transporter, ATP-binding
protein
5601 - 2.38 gi|24378766 oppD 39147 5.47 15 680 56 ATPase activity
Putative sugar ABC transporter, ATP-binding protein 5804 - 7.32 gi|24379552 SMU_1120 55575 5.78 26 1197 62 ATPase activity
Putative amino acid ABC transporter, ATP-binding
protein
6406 - 2.56 gi|24378949 SMU_461 27674 5.83 19 847 75 ATPase activity
Putative amino acid ABC transporter, ATP-binding
protein
7303 - 9.09 gi|24379380 SMU_936 28340 5.90 2 118 10 ATPase activity
Putative phosphate ABC transporter, ATP-binding
protein
7304 - 2.17 gi|24379566 pstB 30276 5.90 3 136 12 ATP binding
Multiple sugar-binding ABC transporter, ATP-binding
protein
7702 - 2.94 gi|24379336 msmK 41938 5.92 14 579 39 ATPase activity
SUGAR BIOSYNTHESIS AND METABOLISM
Putative glucose-1-phosphate thymidyltransferase 2402 - 2.50 gi|24379858 rmlA 32275 4.90 16 917 53 Tranferase activity
Pyruvate kinase 4101 + 2.76 gi|24379618 pykF 54333 5.09 2 70 5 Kinase activity
Glyceraldehyde-3-phosphate dehydrogenase 4601 + 2.28 gi|24378857 gapC 36046 5.71 17 725 44 Oxidoreductase activity
Galactose 6-P isomerase 6102 + 3.01 gi|153674 lacA 19025 5.80 2 84 15 Isomerase activity
Catabolite control protein A 8501 - 6.14 gi|2155300 ccpA 36590 7.08 3 124 9 DNA binding
PROTEIN BIOSYNTHESIS AND FOLDING
60 kDa chaperonin 5102 + 2.19 gi|13898679 cpn60 19827 4.53 2 87 14 Protein binding
Phenylalanyl-tRNA synthetase subunit alpha 6603 - 7.83 gi|24379902 pheS 39271 5.87 14 420 34 Nucleotide binding
30S ribosomal protein S8 9103 + 2.24 gi|24380355 rpsH 14684 9.10 7 411 64 RNA binding
CELL CYCLE AND DIVISION
Putative Hit-like protein 2102 + 2.07 gi|24378905 SMU_412c 15560 5.13 3 139 30 Unknown
Hypothetical protein SMU.471 4002 - 2.04 gi|24378958 SMU471 12972 5.37 5 255 42 Methylase activity
UDP-N-acetylglucosamine 1-carboxyvinyltransferase 1 5702 + 2.30 gi|24379914 murA1 45588 5.65 10 422 30 Tranferase activity
AMINOACIDS BIOSYNTHESIS AND METABOLISM
Uridylate kinase 3302 + 4.08 gi|24380005 pyrH 26315 5.48 9 460 52 Kinase activity
Phospho-2-dehydro-3-deoxyheptonate aldolase 4505 + 2.60 gi|24380198 aroG 39072 6.02 8 338 29 Lyase activity
Shikimate 5-dehydrogenase 5401 + 2.36 gi|24379237 aroE 31791 6.19 2 106 11 Oxidoreductase activity
Putative D-3-phosphoglycerate dehydrogenase 5604 - 3.33 gi|24380031 serA 42771 5.56 14 815 51 Oxidoreductase activity
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Table 3 Identification by nano HPLC-ESI-MS/MS of S. mutansmembrane proteins differentially expressed when treated with 2x LMM fraction of mushroom extract
(Continued)
MISCELLANEOUS
Putative dihydrolipoamide dehydrogenase 3603 + 4.23 gi|24378648 adhD 61708 4.88 4 270 10 Oxidoreductase activity
Orotate phosphoribosyltransferase 4201 + 2.38 gi|24379645 pyrE 22802 5.37 7 381 45 Glycosyltransferase activity
Putative exodeoxyribonuclease III 6403 - 2.56 gi|24380027 smnA 31393 5.72 11 558 44 DNA binding
(3R)-hydroxymyristoyl-ACP dehydratase 7403 - 2.08 gi|24380109 fabZ 15361 8.83 3 150 21 Lyase activity
Not identified 5301 + 4.52
Not identified 8205 + 2.59
Not identified 8401 - 4.35
Not identified 8506 + 3.30
a) Score is –106log(p), where p is the probability that the observed match is a random event, based on the NCBI database using the MASCOT searching program as MS/MS data.
b) Amino acid sequence coverage for the identified protein.
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Table 4 Identification by nano HPLC-ESI-MS/MS of S. mutans cytosol proteins differentially expressed when treated with 2x LMM fraction of mushroom extract
Protein name Spot
no.
Fold of
variation
NCBI acc. # Gene name Theor. Mr.
(Da)
Theor. pI No. of peptides
identified
Mascot
score a)
Sequence
coverage b) (%)
Molecular function
STRESS RESPONSE
60 kDa chaperonin 1605 + 2.17 gi|21666296 groEL 56428 4.68 39 2392 78 Protein binding
Molecular chaperone dnaK 1706 + 2.29 gi|24378606 dnaK 65246 4.58 28 1265 51 Protein binding
10 kDa chaperonin 3001 + 3.25 gi|21666295 groES 10064 4.93 4 273 32 Protein binding
Superoxide dismutase 4108 + 2.60 gi|24379102 sodA 22611 4.99 9 521 56 Ion binding
Glutathione reductase 6607 + 3.89 gi|4587160 gshR 48955 5.40 3 143 7 Oxidoreductase activity
SUGAR BIOSYNTHESIS AND METABOLISM
Glucose-1-phosphate adenylyltransferase 2501 - 3.57 gi|92081399 glgC 41906 4.72 13 680 38 Transferase activity
Phosphopyruvate hydratase 2806 - 2.56 gi|24379669 eno 46829 4.67 14 771 40 Lyase activity
Putative phosphoglucomutase 3703 - 12.50 gi|24379514 pgm 63056 4.88 33 1783 69 Transferase activity
Tagatose 1,6-diphosphate aldolase 1 4303 - 2.17 gi|153676 lacD1 36468 4.96 11 462 31 Lyase activity
Putative N-acetylglucosamine-6-phosphate
isomerase
6205 + 2.43 gi|24379109 SmuNN2025_1351 25457 5.33 7 330 37 Deaminase activity
Fructose bi-phosphate aldolase 8001 + 5.24 gi|4322370 fba 7447 8.85 3 115 30 Lyase activity
PROTEIN BIOSYNTHESIS AND FOLDING
Elongation factor Tu 1603 - 2.44 gi|24379182 tuf 43891 4.84 25 1257 72 GTPase activity
Trigger factor 1701 + 2.06 gi|24378614 tig 47457 4.46 20 918 51 Isomerase activity
50S ribosomal protein L4 3101 + 2.18 gi|254998187 SmuNN2025_1762 22215 9.76 6 313 39 RNA binding
Elongation factor Ts 3503 - 2.38 gi|24380373 tsf 37695 4.91 22 1218 74 GTP binding
CELL REDOX HOMEOSTASIS
Thiol peroxidase 0007 + 4.33 gi|254997527 tpx 17541 4.56 8 450 34 Oxidoreductase activity
Alkyl hydroperoxide reductase 1107 + 12.60 gi|24379223 ahpC 20465 4.57 6 284 34 Oxidoreductase activity
Putative bacterocin transport accessory protein, Bta 5002 + 2.71 gi|24380154 SMU_1788c 12601 5.21 2 85 18 Oxidoreductase activity
Putative glutathione S-transferase 8202 + 5.64 gi|24379712 SMU_1296 29973 5.74 5 243 16 Transferase activity
Not identified 8007 - 3.57
a) Score is –106log(p), where p is the probability that the observed match is a random event, based on the NCBI database using the MASCOT searching program as MS/MS data.
b) Amino acid sequence coverage for the identified protein.
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rated cytoplasmic fraction from membrane fraction of
mushroom treated vs. untreated S. mutans cells has
showed that eight proteins involved in membrane
transport significantly decreased and seven of these
were ABC transporters. ABC systems can be divided
into three functional categories: (i) importers of nutri-
ents, (ii) exporters including toxins and (iii) members
involved in translation of mRNA and DNA repair
[29]. Interestingly, we have observed that transport of
aminoacids, sugars and phosphate is negatively af-
fected. This, in turns, may cause modification of both
sugar and amino acid biosynthesis and metabolism
with about half of the involved proteins up-regulated
and half down-regulated. Quinolones treatment has
been shown to induce expression of ABC efflux system
PatA/Pat B in Streptococcus pneumoniae in order to ex-
trude quinolone molecules from the bacteria cytoplasm
[30]. Furthermore the overexpression of this ABC ef-
flux system is associated whit S. pneumoniae resistance
against quinolones [31]. Our study has not evidenced
modification in efflux system during the mushroom
treatment, thus suggesting that this cannot represent a
biological base for a next acquisition of resistance
against the mushroom extract. Protein biosynthesis and
folding changes may be consistent with the observed
protein synthesis persistence after cell division inhib-
ition. In particular, elongation factors Tu and Ts are
down-regulated. EF-Tu is activated upon GTP binding
and forms a tertiary complex with aminoacylated
elongator tRNAs in order to decode the genetic infor-
mation. This last event triggers GTP hydrolysis and EF-
Tu is released from ribosome. EF-Tu is then recycled
into the active GTP form by the nucleotide-exchange
factor EF-Ts [32]. Down-regulation of EF-Tu and EF-Ts
is consistent with 50% global protein synthesis inhib-
ition as result of treatment.
The cell stress originated during treatment is docu-
mented by the significant increase of stress response pro-
teins such as DnaK, SodA, GroES, GroEL and GshR. The
heat shock chaperon proteins DnaK, GroEL and GroES
bind partially unfolded proteins [33]. These molecular
chaperones bind transiently and noncovalently to nas-
cent polypeptides and unfolded or unassembled proteins
aiding the protein biogenesis. Superoxide dismutase
SodA dismutases superoxide anions which are normally
produced within cells and which are toxic to biological
systems. Glutatione reductase GshR is important for aer-
obic growth in order to protect S. mutans cells from oxi-
dative stress [34]. Similarly, several proteins involved in
cell redox homeostasis are highly overexpressed as effect
of mushroom extract treatment. Redox reactions are
central to both anabolic and catabolic metabolism
and, thus, vital to all organisms. Various molecular sensorscontinually monitor both internal and external environ-
ments adjusting processes involved in maintaining redox
homeostasis. In response to redox imbalance, as results of
several factors including an increase in oxidation reactions
(oxidative stress), new metabolic pathways are initiated
and/or systems that protect the cell from further damage
are induced [35]. Thus, results from S. mutans proteome
analysis, in their whole, are consistent with cell physiology
changes in response to mushroom treatment.
Conclusions
This report has shown an antibiotic-like mode of action
of mushroom and chicory extracts as demonstrated by
induced morphogenetic effects and inhibition of specific
macromolecular synthesis. This feature as well as the
safe use of this extract as result of its natural origin ren-
der the LMM both mushroom and chicory extracts suit-
able for the formulation into products for daily oral
hygiene such as mouthwashes or toothpastes. Further-
more, encouraging the consumption of this food as well
as enriching foods with this bioactive extract may be of
great interest particularly in developing countries where
economic conditions discourage the use of commercially
available products for regular oral hygiene.
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